Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3497 | 1442 | 45.3 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
440 | 3 | NOCICEPTIN//OPIOID RECEPTORS//MORPHINE | 26600 |
3497 | 2 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ | 1442 |
6799 | 1 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ | 1442 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NOCICEPTIN | authKW | 8628455 | 32% | 89% | 459 |
2 | ORPHANIN FQ | authKW | 4880171 | 17% | 96% | 241 |
3 | NOCICEPTIN ORPHANIN FQ | authKW | 4432280 | 16% | 93% | 226 |
4 | NOP RECEPTOR | authKW | 2227866 | 8% | 96% | 110 |
5 | ORL1 RECEPTOR | authKW | 2154023 | 8% | 88% | 115 |
6 | NOCISTATIN | authKW | 1058361 | 4% | 88% | 57 |
7 | ORL1 | authKW | 1022395 | 4% | 93% | 52 |
8 | NOCICEPTIN RECEPTOR | authKW | 790960 | 3% | 91% | 41 |
9 | N OFQ | authKW | 679918 | 2% | 94% | 34 |
10 | UFP 101 | authKW | 598472 | 2% | 91% | 31 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 6288 | 39% | 0% | 563 |
2 | Pharmacology & Pharmacy | 5997 | 38% | 0% | 553 |
3 | Endocrinology & Metabolism | 830 | 10% | 0% | 149 |
4 | Chemistry, Medicinal | 793 | 8% | 0% | 110 |
5 | Biochemistry & Molecular Biology | 476 | 19% | 0% | 274 |
6 | Anesthesiology | 213 | 3% | 0% | 38 |
7 | Physiology | 125 | 4% | 0% | 61 |
8 | Biophysics | 70 | 4% | 0% | 53 |
9 | Behavioral Sciences | 61 | 2% | 0% | 28 |
10 | Chemistry, Organic | 48 | 4% | 0% | 63 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOL SECT | 289230 | 12% | 8% | 174 |
2 | ANAESTHESIA CRIT CARE PAIN MANAGEMENT | 255045 | 2% | 38% | 32 |
3 | EXPT CLIN MED | 147654 | 9% | 6% | 126 |
4 | UNITE NEUROPHARMACOL MOL | 129689 | 0% | 88% | 7 |
5 | PHARMACOL SCI EXPT MED | 67895 | 1% | 18% | 18 |
6 | EXPT MED PUBL HLTH | 65935 | 1% | 17% | 18 |
7 | COTZIAS NEUROONCOL | 48107 | 1% | 23% | 10 |
8 | ANESTHESIOL CARDIOVASC EXCELLENCE | 42348 | 0% | 100% | 2 |
9 | CNRS UMR 6036 | 42348 | 0% | 100% | 2 |
10 | GLOBAL PRECLIN DRUG DEV | 42348 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PEPTIDES | 20854 | 6% | 1% | 93 |
2 | BRITISH JOURNAL OF PHARMACOLOGY | 8749 | 6% | 0% | 86 |
3 | NEUROREPORT | 6315 | 4% | 1% | 59 |
4 | EUROPEAN JOURNAL OF PHARMACOLOGY | 6283 | 6% | 0% | 92 |
5 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 3077 | 4% | 0% | 56 |
6 | NEUROSCIENCE LETTERS | 2793 | 5% | 0% | 65 |
7 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2506 | 2% | 0% | 27 |
8 | BRAIN RESEARCH | 2222 | 5% | 0% | 72 |
9 | NEUROPEPTIDES | 1851 | 1% | 1% | 15 |
10 | NEUROSCIENCE | 1265 | 3% | 0% | 37 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NOCICEPTIN | 8628455 | 32% | 89% | 459 | Search NOCICEPTIN | Search NOCICEPTIN |
2 | ORPHANIN FQ | 4880171 | 17% | 96% | 241 | Search ORPHANIN+FQ | Search ORPHANIN+FQ |
3 | NOCICEPTIN ORPHANIN FQ | 4432280 | 16% | 93% | 226 | Search NOCICEPTIN+ORPHANIN+FQ | Search NOCICEPTIN+ORPHANIN+FQ |
4 | NOP RECEPTOR | 2227866 | 8% | 96% | 110 | Search NOP+RECEPTOR | Search NOP+RECEPTOR |
5 | ORL1 RECEPTOR | 2154023 | 8% | 88% | 115 | Search ORL1+RECEPTOR | Search ORL1+RECEPTOR |
6 | NOCISTATIN | 1058361 | 4% | 88% | 57 | Search NOCISTATIN | Search NOCISTATIN |
7 | ORL1 | 1022395 | 4% | 93% | 52 | Search ORL1 | Search ORL1 |
8 | NOCICEPTIN RECEPTOR | 790960 | 3% | 91% | 41 | Search NOCICEPTIN+RECEPTOR | Search NOCICEPTIN+RECEPTOR |
9 | N OFQ | 679918 | 2% | 94% | 34 | Search N+OFQ | Search N+OFQ |
10 | UFP 101 | 598472 | 2% | 91% | 31 | Search UFP+101 | Search UFP+101 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TOLL, L , BRUCHAS, MR , CALO', G , COX, BM , ZAVERI, NT , (2016) NOCICEPTIN/ORPHANIN FQ RECEPTOR STRUCTURE, SIGNALING, LIGANDS, FUNCTIONS, AND INTERACTIONS WITH OPIOID SYSTEMS.PHARMACOLOGICAL REVIEWS. VOL. 68. ISSUE 2. P. 419 -457 | 276 | 78% | 8 |
2 | SCHRODER, W , LAMBERT, DG , KO, MC , KOCH, T , (2014) FUNCTIONAL PLASTICITY OF THE N/OFQ-NOP RECEPTOR SYSTEM DETERMINES ANALGESIC PROPERTIES OF NOP RECEPTOR AGONISTS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 171. ISSUE 16. P. 3777 -3800 | 211 | 83% | 25 |
3 | CHIOU, LC , LIAO, YY , FAN, PC , KUO, PH , WANG, CH , RIEMER, C , PRINSSEN, EP , (2007) NOCICEPTIN/ORPHANIN FQ PEPTIDE RECEPTORS: PHARMACOLOGY AND CLINICAL IMPLICATIONS.CURRENT DRUG TARGETS. VOL. 8. ISSUE 1. P. 117 -135 | 205 | 94% | 90 |
4 | MOGIL, JS , PASTERNAK, GW , (2001) THE MOLECULAR AND BEHAVIORAL PHARMACOLOGY OF THE ORPHANIN FQ/NOCICEPTIN PEPTIDE AND RECEPTOR FAMILY.PHARMACOLOGICAL REVIEWS. VOL. 53. ISSUE 3. P. 381 -415 | 237 | 74% | 314 |
5 | LAMBERT, DG , (2008) THE NOCICEPTIN/ORPHANIN FQ RECEPTOR: A TARGET WITH BROAD THERAPEUTIC POTENTIAL.NATURE REVIEWS DRUG DISCOVERY. VOL. 7. ISSUE 8. P. 694 -U11 | 177 | 83% | 168 |
6 | ZAVERI, NT , (2016) NOCICEPTIN OPIOID RECEPTOR (NOP) AS A THERAPEUTIC TARGET: PROGRESS IN TRANSLATION FROM PRECLINICAL RESEARCH TO CLINICAL UTILITY.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 15. P. 7011 -7028 | 144 | 97% | 1 |
7 | CALO, G , GUERRINI, R , RIZZI, A , SALVADORI, S , REGOLI, D , (2000) PHARMACOLOGY OF NOCICEPTIN AND ITS RECEPTOR: A NOVEL THERAPEUTIC TARGET.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 129. ISSUE 7. P. 1261 -1283 | 174 | 89% | 279 |
8 | TARIQ, S , NURULAIN, SM , TEKES, K , ADEGHATE, E , (2013) DECIPHERING INTRACELLULAR LOCALIZATION AND PHYSIOLOGICAL ROLE OF NOCICEPTIN AND NOCISTATIN.PEPTIDES. VOL. 43. ISSUE . P. 174-183 | 147 | 91% | 2 |
9 | CALO', G , RIZZI, A , CIFANI, C , DI BONAVENTURA, MVM , REGOLI, D , MASSI, M , SALVADORI, S , LAMBERT, DG , GUERRINI, R , (2011) UFP-112 A POTENT AND LONG-LASTING AGONIST SELECTIVE FOR THE NOCICEPTIN/ORPHANIN FQ RECEPTOR.CNS NEUROSCIENCE & THERAPEUTICS. VOL. 17. ISSUE 3. P. 178 -198 | 141 | 95% | 9 |
10 | WITKIN, JM , STATNICK, MA , RORICK-KEHN, LM , PINTAR, JE , ANSONOFF, M , CHEN, YY , TUCKER, RC , CICCOCIOPPO, R , (2014) THE BIOLOGY OF NOCICEPTIN/ORPHANIN FQ (N/OFQ) RELATED TO OBESITY, STRESS, ANXIETY, MOOD, AND DRUG DEPENDENCE.PHARMACOLOGY & THERAPEUTICS. VOL. 141. ISSUE 3. P. 283-299 | 135 | 74% | 30 |
Classes with closest relation at Level 2 |